TandemAI
PrivateLast Round
Series A
Extension
Nov 13, 2025
Total Funding Raised
$82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TandemAI is a biotechnology company that offers an advanced network platform combining AI-driven computation with large-scale wet lab operations to enhance the speed and affordability of drug discovery for the global scientific community.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TandemAI Comparables
Compare TandemAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 83% | |
| Fathom Therapeutics | 82% | |
| Genesis Molecular AI | 79% | |
TandemAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 13, 2025 | ||||
| Series A | Mar 1, 2023 | ||||
| Seed | Dec 22, 2021 |
Key People
Founding team and executive leadership
TandemAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Series A Extension |
| V-Capital | Series A Extension |
| F-Prime Capital | Series A |
| Eight Roads Ventures | Series A |
| OrbiMed | Series A, Seed |
| Chengwei Capital | Seed |
| F-Prime Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Added Contract Pharma, a media/publishing SMB, as a customer.
- Nov 13, 2025
Raised $22M in a Series A Extension round.
TandemAI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TandemAI's valuation, stock price, and market status.